跳至主要内容
临床试验/CTRI/2022/05/042510
CTRI/2022/05/042510尚未招募3 期

A prospective Nonrandomized open label-controlled study to report the safety aspects of Siddha Polyherbal decoction formulation Kabasura Kudineer on a 28-day trial among participants volunteered from CISF contingent. - SIDDAR

Central Council for Research in Siddha0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Any subjects willing to participate in the study (age 18 -60 yrs) from the contingent, CISF

排除标准

  • 1. Covid positive cases
  • 2. Subjects under immunotherapies or steroids or any other antiviral drugs
  • 3. Subjects who are unsuitable as per the logical derivations of the investigators
  • 4. Subjects are unwilling to enroll/participate or continue the drug period.

研究者

发起方
Central Council for Research in Siddha

相似试验